Department of Visual & Performing Arts

Each area of study - dance, music, theatre and visual arts has a long and strong academic and performance history. From Afro-Caribbean Dance to Jazz Music, Classical Theatre and Graphic Design our talented students are lead by gifted professors whose primary goal is excellence. The mission of the Department of Visual and Performing Arts is to provide students with exceptional professional programs, which combine development in artistic disciplines and career preparation in the arts. These programs are delivered to students through individualized and small group  instruction within a broadly based curriculum. The Department fosters creativity, exploration and discovery in students though inter-disciplinary collaboration and outreach inspiring growth, change and global awareness through the arts. To support this mission, the faculty  subscribes to the highest academic, artistic and ethical standards for themselves and their students. So, we invite you to experience our areas of study and performance events here at North Carolina A&T's Department of Visual & Performing Arts.

 

Contact Us

Visual and Performing Arts
1601 East Market Street
General Classroom Building, Suite A322
Greensboro, NC 27411
Phone: 336-256-2137
Fax: 336-256-2570

 

Upcoming Events

  • RSS Feed

N.C. Board of Governors Honors N.C. A&T Professor with Excellence in Teaching Award

The University of North Carolina Board of Governors has selected Dr. Lisa Owens-Jackson to receive the 2017 Excellence in Teaching Award for N.C. A&T State University.

Zuckerberg, Students Shine in Debut Chancellor’s Town Hall Dialogue

N.C. A&T State University students engaged Facebook founder and CEO Mark Zuckerberg in a wide-ranging and thoughtful conversation as part of the inaugural Chancellor’s Town Hall on March 13.

N.C. A&T and Industry to Bring Novel Aspirin Derivatives to the Marketplace

Dr. Shengmin Sang, a food scientist with N.C. A&T State University, licensed his patent for a family of novel aspirin-derived compounds to SARISA Therapeutics.